KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 96 filers reported holding KALVISTA PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 1.30 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $229,242 | -62.6% | 19,329 | -61.3% | 0.00% | – |
Q4 2023 | $612,500 | -12.7% | 50,000 | -35.8% | 0.00% | – |
Q2 2023 | $701,415 | +110533.3% | 77,935 | -3.4% | 0.00% | – |
Q1 2023 | $634 | -83.7% | 80,703 | -86.0% | 0.00% | -100.0% |
Q4 2022 | $3,895 | -99.9% | 576,251 | +20.6% | 0.00% | -50.0% |
Q3 2022 | $6,935,000 | +602.6% | 477,958 | +376.4% | 0.00% | +300.0% |
Q2 2022 | $987,000 | +290.1% | 100,317 | +485.0% | 0.00% | – |
Q1 2022 | $253,000 | -60.5% | 17,148 | -53.3% | 0.00% | – |
Q3 2021 | $641,000 | +17.2% | 36,715 | +27.5% | 0.00% | – |
Q4 2020 | $547,000 | -30.8% | 28,797 | -54.1% | 0.00% | -100.0% |
Q3 2020 | $790,000 | +37.6% | 62,778 | +32.3% | 0.00% | 0.0% |
Q2 2020 | $574,000 | +14.6% | 47,462 | +68.6% | 0.00% | 0.0% |
Q4 2019 | $501,000 | +205.5% | 28,148 | +98.0% | 0.00% | – |
Q3 2019 | $164,000 | -25.1% | 14,219 | +43.7% | 0.00% | – |
Q2 2019 | $219,000 | -92.1% | 9,895 | -89.7% | 0.00% | -100.0% |
Q1 2019 | $2,761,000 | +139.9% | 96,470 | +85.4% | 0.00% | +300.0% |
Q3 2018 | $1,151,000 | +975.7% | 52,041 | +296.7% | 0.00% | – |
Q2 2018 | $107,000 | -95.1% | 13,117 | -94.3% | 0.00% | -100.0% |
Q1 2018 | $2,173,000 | -5.8% | 229,248 | -3.1% | 0.00% | 0.0% |
Q4 2017 | $2,307,000 | – | 236,584 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG CAPITAL MANAGEMENT LLC | 4,218,829 | $49,697,806 | 5.06% |
Saturn V Capital Management LP | 1,128,478 | $13,293,471 | 5.02% |
VR Adviser, LLC | 6,249,731 | $73,621,831 | 4.69% |
Rosalind Advisors, Inc. | 337,985 | $3,981,463 | 3.06% |
GREAT POINT PARTNERS LLC | 1,338,568 | $15,768,331 | 3.02% |
Nan Fung Group Holdings Ltd | 219,277 | $2,583,083 | 2.76% |
STEMPOINT CAPITAL LP | 736,765 | $8,679,092 | 2.55% |
DAFNA Capital Management LLC | 806,973 | $9,506,142 | 2.27% |
Frazier Life Sciences Management, L.P. | 3,687,867 | $43,443,073 | 2.03% |
First Turn Management, LLC | 1,059,540 | $12,481,381 | 2.03% |